Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience(702 views) Mazziotti G, Formenti AM, Panarotto MB, Arvat E, Chiti A, Cuocolo A, Dottorini ME, Durante C, Agate L, Filetti S, Felicetti F, Filice A, Pace L, Pellegrino T, Rodari M, Salvatori M, Tranfaglia C, Versari A, Viola D, Frara S, Berruti A, Giustina A, Giubbini R
Endocrine (ISSN: 1355-008x, 1355-008xlinking), 2017 Nov 06; 59(1): 90-101.
Keywords: Bone Metastases, Denosumab-Radioiodine, Thyroid Carcinoma, Zoledronate, Radioactive Iodine, Zoledronic Acid, Adolescent, Adult, Aged, Article, Bone Biopsy, Cancer Localization, Cancer Mortality, Cancer Surgery, Cause Of Death, Child, Cohort Analysis, Computer Assisted Tomography, Controlled Study, Differentiated Thyroid Cancer, Disease Association, External Beam Radiotherapy, Female, Hazard Ratio, Human, Hypercalcemia, Informed Consent, Major Clinical Study, Multicenter Study, Nuclear Magnetic Resonance Imaging, Observational Study, Pathologic Fracture, Positron Emission Tomography, Practice Guideline, Priority Journal, Retrospective Study, Spinal Cord Compression, Bone Tumor, Clinical Trial, Middle Aged, Prognosis, Secondary, Thyroid Tumor, Treatment Outcome, Very Elderly, Young Adult, 80 And Over, Bone Neoplasms, Retrospective Studies, Thyroid Neoplasms, Diagnosis, Epidemiology, Bone Neoplasms Diagnosis Epidemiology Secondary Therapy
, Thyroid Neoplasms Diagnosis Epidemiology Pathology Therapy,
Affiliations: *** IBB - CNR ***
Endocrine Unit, ASST Carlo Poma, Mantua, Italy., Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy., Nuclear Medicine, ASST Spedali Civili of Brescia, Brescia, Italy., Nuclear Medicine, University of Brescia, Brescia, Italy., Oncological Endocrinology, University of Turin, Torino, Italy., Nuclear Medicine, Humanitas Research Hospital and Humanitas University, Milan, Italy., Nuclear Medicine, University of Naples Federico II, Napoli, Italy., Nuclear Medicine, "S. Maria della Misericordia" Hospital, Perugia, Italy., Internal Medicine, University Sapienza of Rome, Roma, Italy., Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Nuclear Medicine, Azienda Ospedaliera Santa Maria Nuova-IRCCS Reggio Emilia, Reggio Emilia, Italy., Department of Medicine and Surgery, University of Salerno, Fisciano, Italy., Institute of Biostructure and Bioimaging of the National Research Council of Italy-CNR, Naples, Italy., Nuclear Medicine, Catholic University of Sacred Heart, Rome, Italy., San Raffaele Vita-Salute University, Milan, Italy., Medical Oncology, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy., San Raffaele Vita-Salute University, Milan, Italy. giustina.andrea@hsr.it.,
Nuclear Medicine, “S. Maria della Misericordia” Hospital, Perugia, Italy
Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
Nuclear Medicine, ASST Spedali Civili of Brescia, Brescia, Italy.
Nuclear Medicine, University of Brescia, Brescia, Italy.
Oncological Endocrinology, University of Turin, Torino, Italy.
Nuclear Medicine, Humanitas Research Hospital and Humanitas University, Milan, Italy.
Nuclear Medicine, "S. Maria della Misericordia" Hospital, Perugia, Italy.
Internal Medicine, University Sapienza of Rome, Roma, Italy.
Endocrinology Unit, Department of Clinical and Experimental Medicine, University of
References: Not available.
Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience